UNSPSC 85714462: Fusion of left metacarpocarpal joint with internal fixation device, percutaneous endoscopic approach

This classification denotes the group of activities that yields a surgical intervention or procedure to fusion of left metacarpocarpal joint with internal fixation device, percutaneous endoscopic approach. This surgical intervention or procedure is listed in the World Health Organization's International Statistical Classification of Diseases and Related Health Problems or ICD-10 as code 0RGT44Z

UNSPSC 85714462 Fusion of left metacarpocarpal joint with internal fixation device, percutaneous endoscopic approach is a Commodity code nominally describing a surgical procedure, but recent state and local opportunities show no purchasing activity aligned with that clinical specification. The code appears to have been applied to medical services solicitations that address occupational health surveillance, disability medical evaluations, pharmacy benefit management, temporary health professional staffing, specialty surgical procedure networks, and emergency medical services for detained youth — none of which involve metacarpal fusion surgery or the specific procedural pathway named in the code. State and local buyers do not currently procure this procedure-specific service under this code.

Activity over the past three months spans six solicitations from diverse jurisdicting bodies: the City of Phoenix Retirement Office (disability medical evaluations), the City of Long Beach (surgical procedure carve-out benefits), the Washington State Department of Transportation (occupational medical surveillance), Harris County Juvenile Probation Department (specialty and emergency medical services for detained youth), Collier County Board of County Commissioners (pharmacy benefit management), and the County of Santa Clara Health System (temporary health professional staffing). No geographic cluster or repeat buyer pattern emerges. The recent opportunities posted between July and September 2026 target response dates from September 25 through October 16, 2026, suggesting active procurement pipeline in Q4 2026, but the mismatch between the code's clinical scope and the actual work being bought indicates this code designation is either erroneous or applied inconsistently by these jurisdictions. Firms should verify code alignment with individual solicitations before pursuing opportunities nominally tagged to this commodity code.